Skip to main content

Adicet Bio Inc (ACET) Stock

Adicet Bio Inc Stock Details, Movements and Public Alerts

Stock Details

Adicet Bio Inc (ACET), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.83. Over the past 52 weeks, it has ranged between $0.45 and $1.54. This places the current price at 53.9% of its 52-week high and 85.7% above its 52-week low. The 14-day Relative Strength Index (RSI) stands at 55.19, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $0.74 by 12.16%. Similarly, it is above its 200-day moving average of $0.77 by 7.79%. The MACD histogram is 0.00, indicating neutral momentum (MACD Line: 0.03, Signal Line: 0.03). There is currently 1 active alert set for ACET by users.

Market Cap

$69.93M

52-Week High

$1.54

-46.10% from high

52-Week Low

$0.45

+85.68% from low

Avg Daily Volume

526,048

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

PEG Ratio

0.82

Potentially undervalued

Price to Book

0.52

EV/EBITDA

-1.21

EPS (TTM)

-$1.29

Price to Sales

9.72

Beta

1.61

More volatile than market

How is ACET valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is ACET's risk profile compared to the market?
With a beta of 1.61, Adicet Bio Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 16% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 0.52 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

Return on Equity

-64.40%

Return on Assets

-36.50%

Revenue Growth (YoY)

-100.00%

Earnings Growth (YoY)

0.00%

How profitable and efficient is ACET's business model?
Profitability metrics are not available for this stock.
What are ACET's recent growth trends?
Adicet Bio Inc's revenue declined by 100.00% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Shares Outstanding

83.25M

Book Value/Share

$1.60

Asset Type

Common Stock

What is ACET's market capitalization and position?
Adicet Bio Inc has a market capitalization of $69.93M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 83.25M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does ACET's price compare to its book value?
Adicet Bio Inc's book value per share is $1.60, while the current stock price is $0.83, resulting in a price-to-book (P/B) ratio of 0.52. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$5.60

574.70% upside potential

Analyst Recommendations

Strong Buy

1

Buy

6

Hold

1

Sell

0

Strong Sell

0

How reliable are analyst predictions for ACET?
8 analysts cover ACET with 88% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $5.60 implies 574.7% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on ACET?
Current analyst recommendations:1 Strong Buy, 6 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 1, 2025, 02:20 AM

Earnings Dates

Upcoming Earnings

Q3

Nov 5, 2025

Est. EPS: $-0.30

In 34 days

Technical Indicators

RSI (14-day)

55.19

Neutral

50-Day Moving Average

$0.74

12.16% above MA-50

200-Day Moving Average

$0.77

7.79% above MA-200

MACD Line

0.03

MACD Signal

0.03

MACD Histogram

N/A

Neutral

What does ACET's RSI value tell investors?
The RSI (Relative Strength Index) for ACET is currently 55.19, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret ACET's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.03 below the signal line at 0.03, with histogram at 0.00. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.74) is below the 200-day MA ($0.77), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Oct 2, 2025, 12:42 AM

Active Alerts

Alert Condition
Price rises above
Threshold
$0.90
Created
Oct 1, 2025, 01:37 AM

Stay Ahead of the Market with Adicet Bio Inc Alerts

Set up price alerts for Adicet Bio Inc and get notified instantly when the price hits your target. Never miss an important price movement again.